Canadian stroke best practice recommendations: acute stroke management, practice guidelines update, 2022

…, D Harris, N Kanya-Forstner, E Kaplovitch… - Canadian Journal of …, 2024 - cambridge.org
The 2022 update of the Canadian Stroke Best Practice Recommendations (CSBPR) for
Acute Stroke Management, 7th edition, is a comprehensive summary of current evidence-based …

Is quadriceps endurance reduced in COPD?: a systematic review

RA Evans, E Kaplovitch, MK Beauchamp, TE Dolmage… - Chest, 2015 - Elsevier
BACKGROUND Although the aerobic profile of the quadriceps muscle is reduced in COPD,
there is conflicting evidence regarding whether this leads to reduced quadriceps muscle …

[HTML][HTML] Sex differences in dose escalation and overdose death during chronic opioid therapy: a population-based cohort study

E Kaplovitch, T Gomes, X Camacho, IA Dhalla… - PloS one, 2015 - journals.plos.org
Background The use of opioids for noncancer pain is widespread, and more than 16,000 die
of opioid-related causes in the United States annually. The patients at greatest risk of death …

Periprocedural management of oral anticoagulation

JR Shaw, E Kaplovitch, J Douketis - Medical Clinics, 2020 - medical.theclinics.com
Oral anticoagulation therapy is widely used for stroke prevention in patients with atrial
fibrillation or mechanical heart valves, as well as for the treatment and prevention of venous …

Canadian Cardiovascular Society 2022 guidelines for peripheral arterial disease

…, MA Hussain, VF Huckell, P Jetty, E Kaplovitch… - Canadian Journal of …, 2022 - Elsevier
Patients with widespread atherosclerosis such as peripheral artery disease (PAD) have a
high risk of cardiovascular and limb symptoms and complications, which affects their quality of …

Rivaroxaban and aspirin in patients with symptomatic lower extremity peripheral artery disease: a subanalysis of the COMPASS randomized clinical trial

E Kaplovitch, JW Eikelboom, L Dyal, V Aboyans… - JAMA …, 2021 - jamanetwork.com
Importance Patients with symptomatic lower extremity peripheral artery disease (LE-PAD)
experience an increased risk of major vascular events. There is limited information on what …

Predictors of bleeding in the perioperative anticoagulant use for surgery evaluation study

…, AC Spyropoulos, N Li, E Kaplovitch… - Journal of the …, 2020 - Am Heart Assoc
Background In the PAUSE (Perioperative Anticoagulant Use for Surgery Evaluation) Study,
a simple, standardized, perioperative interruption strategy was provided for patients with …

Treatment in the dental practice of the patient receiving anticoagulation therapy

E Kaplovitch, V Dounaevskaia - The Journal of the American Dental …, 2019 - Elsevier
Background The use of anticoagulants is ubiquitous in outpatient medical practice, with
anticoagulants now among the most common classes of medications prescribed in the United …

[HTML][HTML] Rivaroxaban and aspirin in peripheral vascular disease: a review of implementation strategies and management of common clinical scenarios

GR McClure, E Kaplovitch, S Narula… - Current Cardiology …, 2019 - Springer
Purpose of Review Peripheral artery disease (PAD) affects an estimated 200 million people
worldwide and is associated with significant cardiovascular morbidity and mortality. …

Antithrombotics in stable peripheral artery disease

E Kaplovitch, L Rannelli, SS Anand - Vascular Medicine, 2019 - journals.sagepub.com
Patients with peripheral artery disease (PAD) are at high risk for ischemic cardiovascular
complications. While single antiplatelet therapy (SAPT), predominantly aspirin, has long been …